Chemical Compound Review:
Corgard (2R,3S)-5-[2-hydroxy-3- (tert...
Synonyms:
Nadololum, nadolol, Anabet, Corgaretic, Solgol, ...
Merkel,
Bolognesi,
Sacerdoti,
Bombonato,
Bellini,
Bighin,
Gatta,
Leenen,
Davies,
Fourney,
Dikow,
Kihm,
Zeier,
Kapitza,
Törnig,
Amann,
Tiefenbacher,
Ritz,
Lo,
Lai,
Cheng,
Chen,
Huang,
Hsu,
Lin,
Villanueva,
Miñana,
Ortiz,
Gallego,
Soriano,
Torras,
Sáinz,
Boadas,
Cussó,
Guarner,
Balanzó,
Sanders,
Baker,
Ramer-Quinn,
Kasprowicz,
Fuchs,
Street,
Lo,
Chen,
Chen,
Hsu,
Lin,
Tsai,
Lai,
Schiffelers,
Blaak,
Saris,
van Baak,
- Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. Poynard, T., Calès, P., Pasta, L., Ideo, G., Pascal, J.P., Pagliaro, L., Lebrec, D. N. Engl. J. Med. (1991)
- Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. Villanueva, C., Balanzó, J., Novella, M.T., Soriano, G., Sáinz, S., Torras, X., Cussó, X., Guarner, C., Vilardell, F. N. Engl. J. Med. (1996)
- Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP). Merkel, C., Marin, R., Enzo, E., Donada, C., Cavallarin, G., Torboli, P., Amodio, P., Sebastianelli, G., Sacerdoti, D., Felder, M., Mazzaro, C., Beltrame, P., Gatta, A. Lancet (1996)
- Beta blockade with nadolol in patient with congestive heart-failure. Vukovich, R., Sasahara, A., Sanchez-Zambrano, S., Belko, J. Lancet (1978)
- Nadolol and papilledema. Kaul, S., Wong, M., Singh, B.N., Hepler, R.S. Ann. Intern. Med. (1982)
- Nadolol as a treatment for akathisia. Ratey, J.J., Sorgi, P., Polakoff, S. The American journal of psychiatry. (1985)
- Effects of nadolol on blood pressure, sleep efficiency, and sleep stages. Kales, A., Bixler, E.O., Vela-Bueno, A., Cadieux, R.J., Manfredi, R.L., Bitzer, S., Kantner, T. Clin. Pharmacol. Ther. (1988)
- Use of a long acting peripheral beta blocker, nadolol, in panic disorder. Tollefson, G. Journal of clinical psychopharmacology. (1984)
- Central beta-adrenergic modulation of cognitive flexibility. Beversdorf, D.Q., White, D.M., Chever, D.C., Hughes, J.D., Bornstein, R.A. Neuroreport (2002)
- Titration of nadolol in the treatment of hypertension. Papadoyannis, D.E., Papazachos, G.A., Karatzas, N.B. Eur. J. Clin. Pharmacol. (1982)
- Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. Villanueva, C., Miñana, J., Ortiz, J., Gallego, A., Soriano, G., Torras, X., Sáinz, S., Boadas, J., Cussó, X., Guarner, C., Balanzó, J. N. Engl. J. Med. (2001)
- Redistribution of cardiac output to the kidneys during oral nadolol administration. Textor, S.C., Fouad, F.M., Bravo, E.L., Tarazi, R.C., Vidt, D.G., Gifford, R.W. N. Engl. J. Med. (1982)
- Functional beta3-adrenoceptor in the human heart. Gauthier, C., Tavernier, G., Charpentier, F., Langin, D., Le Marec, H. J. Clin. Invest. (1996)
- Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Lo, G.H., Chen, W.C., Chen, M.H., Hsu, P.I., Lin, C.K., Tsai, W.L., Lai, K.H. Gastroenterology (2002)
- Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. GTIP Gruppo Triveneto per l'Ipertensione Portale. Merkel, C., Gatta, A., Donada, C., Enzo, E., Marin, R., Amodio, P., Torboli, P., Angeli, P., Cavallarin, G., Sebastianelli, G. Hepatology (1995)
- Minoxidil, nadolol, and a diuretic. Once-a-day therapy for resistant hypertension. Spitalewitz, S., Porush, J.G., Reiser, I.W. Arch. Intern. Med. (1986)
- Clinical features and prognosis of patients with out of hospital cardiac arrest and a normal electrophysiologic study. Morady, F., DiCarlo, L., Winston, S., Davis, J.C., Scheinman, M.M. J. Am. Coll. Cardiol. (1984)
- Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade. Leenen, F.H., Davies, R.A., Fourney, A. Clin. Pharmacol. Ther. (1998)
- In vivo electrophysiological effects of a selective slow delayed-rectifier potassium channel blocker in anesthetized dogs: potential insights into class III actions. Nakashima, H., Gerlach, U., Schmidt, D., Nattel, S. Cardiovasc. Res. (2004)
- Morning increase in ambulatory ischemia in patients with stable coronary artery disease. Importance of physical activity and increased cardiac demand. Parker, J.D., Testa, M.A., Jimenez, A.H., Tofler, G.H., Muller, J.E., Parker, J.O., Stone, P.H. Circulation (1994)
- Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Merkel, C., Sacerdoti, D., Bolognesi, M., Enzo, E., Marin, R., Bombonato, G., Angeli, P., Gatta, A. Hepatology (1997)
- Hypotension with postural syncope secondary to the combination of chlorpromazine and captopril. White, W.B. Arch. Intern. Med. (1986)
- Enhancement of nadolol elimination by activated charcoal and antibiotics. du Souich, P., Caillé, G., Larochelle, P. Clin. Pharmacol. Ther. (1983)
- Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Callaerts-Vegh, Z., Evans, K.L., Dudekula, N., Cuba, D., Knoll, B.J., Callaerts, P.F., Giles, H., Shardonofsky, F.R., Bond, R.A. Proc. Natl. Acad. Sci. U.S.A. (2004)
- Different effects of alpha- and beta-adrenergic stimulation on cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes. Gambassi, G., Spurgeon, H.A., Lakatta, E.G., Blank, P.S., Capogrossi, M.C. Circ. Res. (1992)
- The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Merkel, C., Bolognesi, M., Sacerdoti, D., Bombonato, G., Bellini, B., Bighin, R., Gatta, A. Hepatology (2000)
- Nadolol, propranolol, and thyroid hormones: evidence for a membrane-stabilizing action of propranolol. Reeves, R.A., From, G.L., Paul, W., Leenen, F.H. Clin. Pharmacol. Ther. (1985)
- Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study. Idéo, G., Bellati, G., Fesce, E., Grimoldi, D. Hepatology (1988)
- Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Lo, G.H., Lai, K.H., Cheng, J.S., Chen, M.H., Huang, H.C., Hsu, P.I., Lin, C.K. Hepatology (2000)
- Increased infarct size in uremic rats: reduced ischemia tolerance? Dikow, R., Kihm, L.P., Zeier, M., Kapitza, J., Törnig, J., Amann, K., Tiefenbacher, C., Ritz, E. J. Am. Soc. Nephrol. (2004)
- beta3-adrenoceptor control the cystic fibrosis transmembrane conductance regulator through a cAMP/protein kinase A-independent pathway. Leblais, V., Demolombe, S., Vallette, G., Langin, D., Baró, I., Escande, D., Gauthier, C. J. Biol. Chem. (1999)
- In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use. Schiffelers, S.L., Blaak, E.E., Saris, W.H., van Baak, M.A. Clin. Pharmacol. Ther. (2000)
- Oxytocin-induced renin secretion in conscious rats. Huang, W., Sjöquist, M., Skott, O., Stricker, E.M., Sved, A.F. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2000)
- Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. Sanders, V.M., Baker, R.A., Ramer-Quinn, D.S., Kasprowicz, D.J., Fuchs, B.A., Street, N.E. J. Immunol. (1997)
- Catecholaminergic control of NK cell cytolytic activity regulatory factors in the spleen. Dokur, M., Boyadjieva, N., Sarkar, D.K. J. Neuroimmunol. (2004)
- Peripheral beta-adrenergic blockade treatment of parkinsonian tremor. Foster, N.L., Newman, R.P., LeWitt, P.A., Gillespie, M.M., Larsen, T.A., Chase, T.N. Ann. Neurol. (1984)
- Comparison of four beta-blockers as assessed by 24-hour ECG recording. Escoubet, B., Leclercq, J.F., Maison-Blanche, P., Poirier, J.M., Gourmel, B., Delhotal-Landes, B., Coumel, P. Clin. Pharmacol. Ther. (1986)
- Nadolol in essential tremor. Koller, W.C. Neurology (1983)
- Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: comparison between acute and chronic effects. Bolognesi, M., Sacerdoti, D., Merkel, C., Bombonato, G., Enzo, E., Gatta, A. J. Hepatol. (1997)